Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Blin

Showing results (101-110 of 149) with videos related to

Pageof 15
Sort By:
L'Encephale|February 27, 2017
[What role for paraclinical investigations within clinical trials conducted in psychiatric patients?]A Kaladjian, M Adida, N Simon, et al.
Revue Neurologique|January 1, 1993
[Iatrogenic axonal neuropathy and erythroderma induced by piroxicam. Manifestations of hypersensitivity?]I Sangla, O Blin, J Jouglard, et al.
Schizophrenia Research|November 25, 2010
Correlated structural and functional brain abnormalities in the default mode network in schizophrenia patientsP Salgado-Pineda, E Fakra, P Delaveau, et al.
Presse Medicale (Paris, France : 1983)|March 3, 1990
[An unusual association of myasthenia and T8 lymphoid leukemia]G Kaplanski, C Desnuelle, J R Harle, et al.
Advances in Neurology|January 1, 1996
Effects of L-DOPA on spatiotemporal contrast sensitivity in Parkinson's diseaseD R Mestre, O Blin, C L van den Brand, et al.
Neuropsychobiology|January 25, 2014
Structural abnormalities in schizophrenia: further evidence on the key role of the anterior cingulate cortexP Salgado-Pineda, R Landin-Romero, E Fakra, et al.
Psychopharmacology|June 26, 2008
Effect of risperidone versus haloperidol on emotional responding in schizophrenic patientsE Fakra, S Khalfa, D Da Fonseca, et al.
International Journal of Antimicrobial Agents|August 3, 2020
Aminoglycosides in critically ill patients: which dosing regimens for which pathogens?A Marsot, S Hraiech, N Cassir, et al.
Behavioural Brain Research|March 4, 2000
Lorazepam-induced modifications of saccadic and smooth-pursuit eye movements in humans: attentional and motor factorsG S Masson, D R Mestre, F Martineau, et al.
Clinical Neuropharmacology|April 18, 2001
Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteersO Blin, N Simon, E Jouve, et al.
Pageof 15

Showing results (101-110 of 149) with videos related to

Sort By:
Pageof 15
L'Encephale|February 27, 2017
[What role for paraclinical investigations within clinical trials conducted in psychiatric patients?]A Kaladjian, M Adida, N Simon, et al.
Revue Neurologique|January 1, 1993
[Iatrogenic axonal neuropathy and erythroderma induced by piroxicam. Manifestations of hypersensitivity?]I Sangla, O Blin, J Jouglard, et al.
Schizophrenia Research|November 25, 2010
Correlated structural and functional brain abnormalities in the default mode network in schizophrenia patientsP Salgado-Pineda, E Fakra, P Delaveau, et al.
Presse Medicale (Paris, France : 1983)|March 3, 1990
[An unusual association of myasthenia and T8 lymphoid leukemia]G Kaplanski, C Desnuelle, J R Harle, et al.
Advances in Neurology|January 1, 1996
Effects of L-DOPA on spatiotemporal contrast sensitivity in Parkinson's diseaseD R Mestre, O Blin, C L van den Brand, et al.
Neuropsychobiology|January 25, 2014
Structural abnormalities in schizophrenia: further evidence on the key role of the anterior cingulate cortexP Salgado-Pineda, R Landin-Romero, E Fakra, et al.
Psychopharmacology|June 26, 2008
Effect of risperidone versus haloperidol on emotional responding in schizophrenic patientsE Fakra, S Khalfa, D Da Fonseca, et al.
International Journal of Antimicrobial Agents|August 3, 2020
Aminoglycosides in critically ill patients: which dosing regimens for which pathogens?A Marsot, S Hraiech, N Cassir, et al.
Behavioural Brain Research|March 4, 2000
Lorazepam-induced modifications of saccadic and smooth-pursuit eye movements in humans: attentional and motor factorsG S Masson, D R Mestre, F Martineau, et al.
Clinical Neuropharmacology|April 18, 2001
Pharmacokinetic and pharmacodynamic analysis of sedative and amnesic effects of lorazepam in healthy volunteersO Blin, N Simon, E Jouve, et al.
Pageof 15